Innovative Universal CAR-T Therapy Shows Promise in Treating Aggressive T Cell Blood Cancers
A pioneering form of immunotherapy targeting some of the most aggressive and difficult-to-treat blood cancers has demonstrated significant clinical promise, coupled with a manageable safety profile, according to new findings from an international phase 1/2 clinical trial. Led by researchers at Washington University School of Medicine in St. Louis, the study highlights a potential paradigm […]
